Brad H. Rovin
Department of Medicine
The Ohio State University College of Medicine and Public Health
Columbus
USA
Name/email consistency: high
- Biomarkers for lupus nephritis: the quest continues. Rovin, B.H., Zhang, X. Clin. J. Am. Soc. Nephrol (2009)
- Can we personalize treatment for kidney diseases?. Rovin, B.H., McKinley, A.M., Birmingham, D.J. Clinical J. American Society Nephrology : Cjasn (2009)
- The chemokine network in systemic lupus erythematous nephritis. Rovin, B.H. Front. Biosci. (2008)
- Biomarker discovery in human SLE nephritis. Rovin, B.H., Birmingham, D.J., Nagaraja, H.N., Yu, C.Y., Hebert, L.A. Bulletin. Nyu. Hospital. Joint. Diseases (2007)
- Chemokine induction by the adipocyte-derived cytokine adiponectin. Rovin, B.H., Song, H. Clin. Immunol. (2006)
- 15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. Rovin, B.H., Wilmer, W.A., Lu, L., Doseff, A.I., Dixon, C., Kotur, M., Hilbelink, T. Kidney Int. (2002)
- A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Rovin, B.H., Lu, L., Zhang, X. Kidney Int. (2002)
- Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta. Rovin, B.H., Lu, L., Marsh, C.B. J. Leukoc. Biol. (2001)
- Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells. Rovin, B.H., Lu, L., Cosio, A. J. Am. Soc. Nephrol. (2001)
- Chemokine blockade as a therapy for renal disease. Rovin, B.H. Curr. Opin. Nephrol. Hypertens. (2000)
- A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Rovin, B.H., Lu, L., Saxena, R. Biochem. Biophys. Res. Commun. (1999)
- Chemokines as therapeutic targets in renal inflammation. Rovin, B.H. Am. J. Kidney Dis. (1999)
- Chemotactic factors and renal inflammation. Rovin, B.H., Phan, L.T. Am. J. Kidney Dis. (1998)